Posts classified under: General

HebeCell and Logomix Announce Collaboration for the Development of Next Gen Genomically Engineered PSC-NK CellsAugust 14, 2023
HebeCell Raises $53 Million in Series A Financing to Advance Unique Off-The-Shelf PSC-CAR-NK Products Into ClinicsAugust 31, 2021
President and CEO John Lu’s Interview on Key Developments, Technologies & Challenges in Asia’s Cell & Gene Therapy Industry by IMAPACAugust 25, 2021
Proteintech and HebeCell Announce Collaboration on Nanobody iPSC-derived Natural Killer CellsNovember 11, 2020
Ankarys Therapeutics, Applied StemCell, and HebeCell Corp Announces Strategic Collaboration on iPSC-derived CAR-NK Cell TherapeuticsOctober 20, 2020

21 Strathmore Rd, Natick,
MA, 01760, United States
+1 (508) 545- 2190
Info@hebecell.com

Website Design & Development by Noble House Media Group